DIFFICULTIES OF MINIMAL RESIDUAL DISEASE MONITORING BY NESTED PCR IN TEL-AML1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN

被引：0
|
作者：
Colita, A. [1 ]
Radu, L. E. [1 ]
Dumitru, J. [2 ]
Dragomir, M. [2 ]
Jardan, C. [3 ]
Gheorghe, A. [4 ]
Coriu, D. [1 ]
Arion, C. [1 ]
机构：
[1] Fundeni Clin Inst, Bucharest, Romania
[2] Fundeni Clin Inst, Mol Biol Lab, Bucharest, Romania
[3] Fundeni Clin Inst, Genet Lab, Bucharest, Romania
[4] Fundeni Clin Inst, Immunophenotyping Lab, Bucharest, Romania
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1406
引用
收藏
页码：549 / 549
页数：1
相关论文
共 50 条
  • [41] TEL-AML1 frequency in multi-ethnic Malaysian pediatric acute lymphoblastic leukemia
    Gill, HK
    Keoh, TS
    Dhaliwal, JS
    Moore, S
    Kim, TS
    Hassan, R
    Karim, FA
    Zakaria, Z
    Murad, S
    Mohamed, M
    Ho, CML
    Ibrahim, H
    Juraida, E
    Rahman, EJA
    CANCER GENETICS AND CYTOGENETICS, 2005, 156 (02) : 129 - 133
  • [42] Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes
    Ford, AM
    Fasching, K
    Panzer-Grümayer, ER
    Koenig, M
    Haas, OA
    Greaves, MF
    BLOOD, 2001, 98 (03) : 558 - 564
  • [43] Translocation ETS leukemia-acute myeloid leukemia 1 (TEL-AML1) gene fusion in childhood acute lymphoblastic leukemia
    Mulatsih, Sri
    Liang, Yeow
    Yeoh, Allen
    Sutaryo
    Sunarto
    PAEDIATRICA INDONESIANA, 2009, 49 (05) : 270 - 275
  • [44] The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemia
    de Haas, V
    Breunis, WB
    Dee, R
    Verhagen, OJHM
    Kroes, W
    van Wering, ER
    van Dongen, JJM
    van den Berg, H
    van der Schoot, CE
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (01) : 87 - 93
  • [45] Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero
    Wiemels, JL
    Ford, AM
    Van Wering, ER
    Postma, A
    Greaves, M
    BLOOD, 1999, 94 (03) : 1057 - 1062
  • [46] Minimal residual disease monitoring in childhood acute lymphoblastic leukemia
    Campana, Dario
    CURRENT OPINION IN HEMATOLOGY, 2012, 19 (04) : 313 - 318
  • [47] International note -: Characteristics of TEL/AML-1 positive acute lymphoblastic leukemia in Hungarian children
    Pajor, L
    Lacza, A
    Jáksó, P
    Kajtár, B
    MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 37 (04): : 409 - 411
  • [48] Prospective assessment of the prognostic value of TEL-AML1 expression in childhood acute lymphoblastic leukemia (ALL).
    Baruchel, A
    Cayuela, JM
    Landman, J
    Perel, Y
    Ballerini, P
    Michel, G
    Gabert, J
    Vermylen, C
    Schmitt, C
    Vannier, JP
    Gandemer, V
    Debre, M
    Cayre, Y
    Schaison, G
    Leblanc, T
    Macintyre, E
    Auclerc, MF
    Leverger, G
    BLOOD, 1999, 94 (10) : 502A - 502A
  • [49] Advanced Minimal Residual Disease Monitoring for Acute Lymphoblastic Leukemia with Multiplex Mediator Probe PCR
    Kipf, Elena
    Schlenker, Franziska
    Borst, Nadine
    Fillies, Marion
    Kirschner-Schwabe, Renate
    Zengerle, Roland
    Eckert, Cornelia
    von Stetten, Felix
    Lehnert, Michael
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (01): : 57 - 68
  • [50] Over-expression of the erythropoietin receptor (EpoR) in TEL-AML1 positive acute lymphoblastic leukaemia
    Breen, M.
    Hodges, V. M.
    Zaliova, M.
    Trka, J.
    Lappin, T. R. J.
    Mills, K. I.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 : 14 - 14
12345